Results 71 to 80 of about 9,669 (183)

Investigating preparation and characterisation of diphtheria toxoid-loaded on sodium alginate nanoparticles. [PDF]

open access: yesIET Nanobiotechnol, 2022
Aghamiri S   +4 more
europepmc   +1 more source

The Improvement of Adaptive Immune Responses towards COVID-19 Following Diphtheria–Tetanus–Pertussis and SARS-CoV-2 Vaccinations in Indonesian Children: Exploring the Roles of Heterologous Immunity

open access: yesVaccines
Background: Routine childhood vaccination, e.g., for diphtheria, tetanus, and pertussis (DTP), might provide additional protection against SARS-CoV-2 infection. This concept of heterologous immunity was explored in healthy children receiving both DTP and
Theresia Santi   +9 more
doaj   +1 more source

Pseudomonas aeruginosa PAO1 outer membrane vesicles-diphtheria toxoid conjugate as a vaccine candidate in a murine burn model. [PDF]

open access: yesSci Rep, 2022
Zare Banadkoki E   +5 more
europepmc   +1 more source

Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Background: An acellular Pertussis (aP) vaccine containing recombinant genetically detoxified Pertussis Toxin (PTgen), Filamentous Hemagglutinin (FHA) and Pertactin (PRN) has been developed by BioNet-Asia (BioNet).
Chukiat Sirivichayakul   +9 more
doaj   +1 more source

Validation of a diphtheria toxoid multiplex bead assay for serosurveys. [PDF]

open access: yesDiagn Microbiol Infect Dis, 2021
Scobie HM   +3 more
europepmc   +1 more source

Seroprevalence of Diphtheria and Tetanus Immunoglobulin G among the General Health Population in Guangzhou, China

open access: yesVaccines
A seroepidemiological study was conducted in 2018 to assess diphtheria and tetanus antibodies in Guangzhou, China. Diphtheria and tetanus antibody concentrations were measured with an enzyme-linked immunosorbent assay.
Qing He   +4 more
doaj   +1 more source

A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal. [PDF]

open access: yesHum Vaccin Immunother, 2023
Chaudhary S   +14 more
europepmc   +1 more source

Epitope Profiling of Diphtheria Toxoid Provides Enhanced Monitoring for Consistency Testing during Manufacturing Process Changes. [PDF]

open access: yesVaccines (Basel), 2022
Houy C   +7 more
europepmc   +1 more source

The geometry of diphtheria toxoid CRM197 channel assessed by thiazolium salts and nonelectrolytes. [PDF]

open access: yesBiophys J, 2021
Shatursky OY   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy